NRXP

NRXP

USD

NRX Pharmaceuticals Inc. Common Stock

$2.450-0.220 (-8.240%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.670

Máximo

$2.700

Mínimo

$2.440

Volumen

0.08M

Fundamentos de la Empresa

Capitalización de Mercado

58.2M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.49M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.12Actual $2.450Máximo $6.01

Noticias Relacionadas

Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

Ver más
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target
GlobeNewswire

HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health

ONE-D is the first reported protocol to achieve remission from treatment-resistant depression with a single day of treatment, using an FDA-cleared device.HOPE is one of the first Ampa deployments nationwide and is now

Ver más
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
Analyst Upgrades

Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals with a Buy and raises the price target from $46 to $47.

Ver más
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $47
Analyst Upgrades

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals with a Buy and maintains $34 price target.

Ver más
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.